5PSQ-071 Real-world results of effectiveness and security of erenumab and galcanezumab in migraine patients

Autor: A Gracia Moya, C Varon Galcera, I Cardona Pascual, E Florensa Royo, J Vidal Otero, G Vancells Lujan, MQ Gorgas Torner
Rok vydání: 2022
Zdroj: Section 7: Post Congress additions.
DOI: 10.1136/ejhpharm-2022-eahp.421
Databáze: OpenAIRE